51
|
van Lammeren G, den Hartog A, Pasterkamp G, Vink A, de Vries JP, Moll F, de Borst G. Asymptomatic Carotid Artery Stenosis: Identification of Subgroups with Different Underlying Plaque Characteristics. Eur J Vasc Endovasc Surg 2012; 43:632-6. [DOI: 10.1016/j.ejvs.2012.03.011] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2011] [Accepted: 03/21/2012] [Indexed: 11/29/2022]
|
52
|
Platelets enter atherosclerotic plaque via intraplaque microvascular leakage and intraplaque hemorrhage: A histopathological study in carotid plaques. Atherosclerosis 2012; 222:355-9. [DOI: 10.1016/j.atherosclerosis.2012.03.008] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/08/2011] [Revised: 01/20/2012] [Accepted: 03/07/2012] [Indexed: 11/21/2022]
|
53
|
Rensing K, von der Thüsen J, Weijers E, Houttuijn Bloemendaal F, van Lammeren G, Vink A, van der Wal A, van Hinsbergh V, van der Loos C, Stroes E, Koolwijk P, Twickler T. Endothelial insulin receptor expression in human atherosclerotic plaques: Linking micro- and macrovascular disease in diabetes? Atherosclerosis 2012; 222:208-15. [DOI: 10.1016/j.atherosclerosis.2012.01.035] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/19/2011] [Revised: 01/20/2012] [Accepted: 01/21/2012] [Indexed: 10/14/2022]
|
54
|
Herder C, Peeters W, Zierer A, de Kleijn DPV, Moll FL, Karakas M, Roden M, Meisinger C, Thorand B, Pasterkamp G, Koenig W. TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary events. Eur J Clin Invest 2012; 42:329-37. [PMID: 21950567 DOI: 10.1111/j.1365-2362.2011.02587.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
BACKGROUND We tested the hypothesis that high TGF-β1 content in atherosclerotic plaques and high TGF-β1 serum levels are associated with lower risk of coronary events in two independent prospective studies. MATERIALS AND METHODS In the prospective Athero-Express biobank study, total TGF-β1 plaque levels were measured in 632 atherosclerotic lesions from patients who underwent carotid endarterectomy. In a population-based case-cohort study within the Monitoring of trends and determinants in cardiovascular disease (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) Augsburg studies, baseline total TGF-β1 serum levels were measured in 333 individuals with and 1728 without incident coronary events. RESULTS Patients with TGF-β1 content in their plaques above the study median did not have a lower risk of coronary events than patients with lower TGF-β1 levels [adjusted HR (95% CI) 1·46 (0·83-2·53); P = 0·16; mean follow-up 2·6 ± 0·7 years] in the Athero-Express biobank study. Cox proportional hazard models adjusting for age, sex, body mass index, metabolic factors, lifestyle factors and survey did not reveal a significant association between TGF-β1 serum levels and incident coronary events [HR (95% CI) for increasing TGF-β1 tertiles 1·0, 1·22 (0·88-1·68), 1·13 (0·82-1·57); P = 0·47; mean follow-up: 10·8 ± 4·6 years] in the MONICA/KORA Augsburg studies. CONCLUSION Our results indicate that high TGF-β1 content in human atherosclerotic plaques and high serum levels of TGF-β1 are not associated with reduced risk of coronary events.
Collapse
Affiliation(s)
- Christian Herder
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
55
|
Herder C, Peeters W, Illig T, Baumert J, de Kleijn DPV, Moll FL, Poschen U, Klopp N, Müller-Nurasyid M, Roden M, Preuss M, Karakas M, Meisinger C, Thorand B, Pasterkamp G, Koenig W, Assimes TL, Deloukas P, Erdmann J, Holm H, Kathiresan S, König IR, McPherson R, Reilly MP, Roberts R, Samani NJ, Schunkert H, Stewart AFR. RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studies. PLoS One 2011; 6:e25734. [PMID: 22162987 PMCID: PMC3232218 DOI: 10.1371/journal.pone.0025734] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2011] [Accepted: 09/09/2011] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND The chemokine RANTES (regulated on activation, normal T-cell expressed and secreted)/CCL5 is involved in the pathogenesis of cardiovascular disease in mice, whereas less is known in humans. We hypothesised that its relevance for atherosclerosis should be reflected by associations between CCL5 gene variants, RANTES serum concentrations and protein levels in atherosclerotic plaques and risk for coronary events. METHODS AND FINDINGS We conducted a case-cohort study within the population-based MONICA/KORA Augsburg studies. Baseline RANTES serum levels were measured in 363 individuals with incident coronary events and 1,908 non-cases (mean follow-up: 10.2±4.8 years). Cox proportional hazard models adjusting for age, sex, body mass index, metabolic factors and lifestyle factors revealed no significant association between RANTES and incident coronary events (HR [95% CI] for increasing RANTES tertiles 1.0, 1.03 [0.75-1.42] and 1.11 [0.81-1.54]). None of six CCL5 single nucleotide polymorphisms and no common haplotype showed significant associations with coronary events. Also in the CARDIoGRAM study (>22,000 cases, >60,000 controls), none of these CCL5 SNPs was significantly associated with coronary artery disease. In the prospective Athero-Express biobank study, RANTES plaque levels were measured in 606 atherosclerotic lesions from patients who underwent carotid endarterectomy. RANTES content in atherosclerotic plaques was positively associated with macrophage infiltration and inversely associated with plaque calcification. However, there was no significant association between RANTES content in plaques and risk for coronary events (mean follow-up 2.8±0.8 years). CONCLUSIONS High RANTES plaque levels were associated with an unstable plaque phenotype. However, the absence of associations between (i) RANTES serum levels, (ii) CCL5 genotypes and (iii) RANTES content in carotid plaques and either coronary artery disease or incident coronary events in our cohorts suggests that RANTES may not be a novel coronary risk biomarker. However, the potential relevance of RANTES levels in platelet-poor plasma needs to be investigated in further studies.
Collapse
Affiliation(s)
- Christian Herder
- Institute for Clinical Diabetology, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
56
|
Masteling MG, Zeebregts CJ, Tio RA, Breek JC, Tietge UJF, de Boer JF, Glaudemans AWJM, Dierckx RAJO, Boersma HH, Slart RHJA. High-resolution imaging of human atherosclerotic carotid plaques with micro 18F-FDG PET scanning exploring plaque vulnerability. J Nucl Cardiol 2011; 18:1066-75. [PMID: 22002650 PMCID: PMC3225624 DOI: 10.1007/s12350-011-9460-2] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2011] [Accepted: 09/22/2011] [Indexed: 11/28/2022]
Abstract
AIMS FDG-PET can be used to identify vulnerable plaques in atherosclerotic disease. Clinical FDG-PET camera systems are restricted in terms of resolution for the visualization of detailed inflammation patterns in smaller vascular structures. The aim of the study is to evaluate the possible added value of a high-resolution microPET system in excised carotid plaques using FDG. METHODS AND RESULTS In this study, 17 patients with planned carotid endarterectomy were included. Excised plaques were incubated in FDG and subsequently imaged with microPET. Macrophage presence in plaques was evaluated semi-quantitatively by immunohistochemistry. Plaque calcification was assessed additionally with CT and correlated to FDG uptake. Finally, FDG uptake and macrophage infiltration were compared with patient symptomatology. Heterogeneous distributions and variable intensities of FDG uptake were found within the plaques. A positive correlation between the distribution of macrophages and the FDG uptake (r = 0.68, P < .01) was found. A negative correlation was found between areas of calcifications and FDG uptake (r = -0.84, P < .001). Ratio FDG(max) values as well as degree of CD68 accumulation were significantly higher in CVA patients compared with TIA or amaurosis fugax patients (P < .05) and CVA patients compared with asymptomatic patients (P < .05). CONCLUSION This ex vivo study demonstrates that excised carotid plaques can be visualized in detail using FDG microPET. Enhancement of clinical PET/CT resolution for similar imaging results in patients is needed.
Collapse
Affiliation(s)
- Marleen G. Masteling
- Faculty of Medicine, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
| | - Clark J. Zeebregts
- Division of Vascular Surgery, Department of Surgery, University Medical Center Groningen (UMCG), University of Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands
- Cardiovascular Imaging Group Groningen, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
| | - René A. Tio
- Cardiovascular Imaging Group Groningen, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
- Department of Cardiology, Thorax Center, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
| | - Jan-Cees Breek
- Department of Surgery, Martini Hospital, Groningen, The Netherlands
| | - Uwe J. F. Tietge
- Department of Pediatrics, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
| | - Jan Freark de Boer
- Department of Pediatrics, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
| | - Andor W. J. M. Glaudemans
- Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
| | - Rudi A. J. O. Dierckx
- Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
| | - Hendrikus H. Boersma
- Cardiovascular Imaging Group Groningen, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
- Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
- Department of Hospital and Clinical Pharmacy, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
| | - Riemer H. J. A. Slart
- Cardiovascular Imaging Group Groningen, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
- Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands
| |
Collapse
|
57
|
Derksen WJM, Peeters W, van Lammeren GW, Tersteeg C, de Vries JPPM, de Kleijn DPV, Moll FL, van der Wal AC, Pasterkamp G, Vink A. Different stages of intraplaque hemorrhage are associated with different plaque phenotypes: A large histopathological study in 794 carotid and 276 femoral endarterectomy specimens. Atherosclerosis 2011; 218:369-77. [PMID: 21868015 DOI: 10.1016/j.atherosclerosis.2011.07.104] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/02/2011] [Revised: 07/12/2011] [Accepted: 07/23/2011] [Indexed: 11/15/2022]
Affiliation(s)
- Wouter J M Derksen
- Experimental Cardiology Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands
| | | | | | | | | | | | | | | | | | | |
Collapse
|
58
|
van Lammeren GW, Reichmann BL, Moll FL, Bots ML, de Kleijn DPV, de Vries JPPM, Pasterkamp G, de Borst GJ. Atherosclerotic plaque vulnerability as an explanation for the increased risk of stroke in elderly undergoing carotid artery stenting. Stroke 2011; 42:2550-5. [PMID: 21737811 DOI: 10.1161/strokeaha.110.607382] [Citation(s) in RCA: 69] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE Recent randomized trials showed an increased periprocedural risk for stroke with increasing age in patients undergoing carotid artery stenting. Manipulation of atherosclerotic plaques during carotid artery stenting can result in plaque rupture with subsequent superimposed thrombus formation, embolization, and cerebrovascular events. We hypothesized that atherosclerotic plaques become more unstable with increasing age and thereby might provide insight into the age-related increased risk of cerebrovascular events during carotid artery stenting. METHODS Carotid atherosclerotic plaques were harvested from 1385 consecutive patients undergoing carotid endarterectomy between 2002 and 2010. Carotid plaques were quantitatively analyzed for macrophages, smooth muscle cells, and microvessels; and semiquantitatively analyzed for collagen, calcifications lipid cores, and intraplaque hemorrhages. Patients were divided in 4 groups by age: <60, 60 to 69, 70 to 79, and ≥80 years. Measures of association between age as a continuous variable and histological characteristics were also calculated. RESULTS Increasing age was associated with a decrease in the amount of smooth muscle cells in the carotid plaque. More plaques with large atheroma and heavy plaque calcifications were observed among elderly patients. After correction for baseline differences, risk factors, and medication use, age was independently associated with a more vulnerable carotid plaque composition. CONCLUSIONS Plaque stability decreases gradually with age. Older patients with carotid stenosis have relatively unstable plaques with low smooth muscle cell content, a high amount of large lipid cores, and more calcified plaques as compared with younger patients. The underlying vulnerable plaque composition in the elderly might be an important contributing factor to the increased risk of stroke for older patients undergoing carotid artery stenting.
Collapse
Affiliation(s)
- Guus W van Lammeren
- Department of Vascular Surgery, University Medical Center Utrecht, PO Box 85500, Room G04.129 3508GA, Utrecht, The Netherlands
| | | | | | | | | | | | | | | |
Collapse
|
59
|
van Lammeren GW, Peeters W, de Vries JPP, de Kleijn DP, De Borst GJ, Pasterkamp G, Moll FL. Restenosis After Carotid Surgery. Stroke 2011; 42:965-71. [DOI: 10.1161/strokeaha.110.603746] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Guus W. van Lammeren
- From the Experimental Cardiology Laboratory (G.W.v.L., D.P.V.d.K., G.P.), University Medical Center Utrecht, Utrecht, The Netherlands; the Department of Vascular Surgery (G.W.v.L., J.P.P.M.d.V.), St Antonius Hospital Nieuwegein, The Netherlands; and the Department of Vascular Surgery (W.P., G.J.d.B., F.L.M.), University Medical Center Utrecht, Utrecht, The Netherlands
| | - Wouter Peeters
- From the Experimental Cardiology Laboratory (G.W.v.L., D.P.V.d.K., G.P.), University Medical Center Utrecht, Utrecht, The Netherlands; the Department of Vascular Surgery (G.W.v.L., J.P.P.M.d.V.), St Antonius Hospital Nieuwegein, The Netherlands; and the Department of Vascular Surgery (W.P., G.J.d.B., F.L.M.), University Medical Center Utrecht, Utrecht, The Netherlands
| | - Jean-Paul P.M. de Vries
- From the Experimental Cardiology Laboratory (G.W.v.L., D.P.V.d.K., G.P.), University Medical Center Utrecht, Utrecht, The Netherlands; the Department of Vascular Surgery (G.W.v.L., J.P.P.M.d.V.), St Antonius Hospital Nieuwegein, The Netherlands; and the Department of Vascular Surgery (W.P., G.J.d.B., F.L.M.), University Medical Center Utrecht, Utrecht, The Netherlands
| | - Dominique P.V. de Kleijn
- From the Experimental Cardiology Laboratory (G.W.v.L., D.P.V.d.K., G.P.), University Medical Center Utrecht, Utrecht, The Netherlands; the Department of Vascular Surgery (G.W.v.L., J.P.P.M.d.V.), St Antonius Hospital Nieuwegein, The Netherlands; and the Department of Vascular Surgery (W.P., G.J.d.B., F.L.M.), University Medical Center Utrecht, Utrecht, The Netherlands
| | - Gert-Jan De Borst
- From the Experimental Cardiology Laboratory (G.W.v.L., D.P.V.d.K., G.P.), University Medical Center Utrecht, Utrecht, The Netherlands; the Department of Vascular Surgery (G.W.v.L., J.P.P.M.d.V.), St Antonius Hospital Nieuwegein, The Netherlands; and the Department of Vascular Surgery (W.P., G.J.d.B., F.L.M.), University Medical Center Utrecht, Utrecht, The Netherlands
| | - Gerard Pasterkamp
- From the Experimental Cardiology Laboratory (G.W.v.L., D.P.V.d.K., G.P.), University Medical Center Utrecht, Utrecht, The Netherlands; the Department of Vascular Surgery (G.W.v.L., J.P.P.M.d.V.), St Antonius Hospital Nieuwegein, The Netherlands; and the Department of Vascular Surgery (W.P., G.J.d.B., F.L.M.), University Medical Center Utrecht, Utrecht, The Netherlands
| | - Frans L. Moll
- From the Experimental Cardiology Laboratory (G.W.v.L., D.P.V.d.K., G.P.), University Medical Center Utrecht, Utrecht, The Netherlands; the Department of Vascular Surgery (G.W.v.L., J.P.P.M.d.V.), St Antonius Hospital Nieuwegein, The Netherlands; and the Department of Vascular Surgery (W.P., G.J.d.B., F.L.M.), University Medical Center Utrecht, Utrecht, The Netherlands
| |
Collapse
|
60
|
The effect of alcohol on atherosclerotic plaque composition and cardiovascular events in patients with arterial occlusive disease. J Vasc Surg 2011; 54:123-31. [PMID: 21367564 DOI: 10.1016/j.jvs.2010.12.039] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2010] [Revised: 12/08/2010] [Accepted: 12/08/2010] [Indexed: 11/21/2022]
Abstract
OBJECTIVES This study examined the association between alcohol use, the occurrence of cardiovascular events, and plaque phenotype in patients after femoral or carotid endarterectomy for arterial occlusive disease. Alcohol has been shown to have cardiovascular protective effects in patients with cardiovascular disease as well as in healthy individuals. Whether alcohol consumption induces changes in atherosclerotic plaque composition has not been investigated. METHODS Consecutive femoral (n = 224) and carotid (n = 693) endarterectomy specimens underwent histologic examination for the presence of collagen, calcifications, smooth muscle cells, macrophages, fat, and intraplaque thrombus. Patients were monitored for 3 years after the initial operation and investigated for the occurrence of cardiovascular events. Primary outcome was the composite end point "major cardiovascular event." Alcohol consumption was categorized as no alcohol use, 1 to 10 U/wk, or >10 U/wk. RESULTS The Kaplan-Meier estimate of the major cardiovascular event rate after 3 years of follow-up in the femoral group was 35% for no alcohol use and 21% for 1 to 10 U/wk, whereas only 10% of the group >10 U/wk sustained a major cardiovascular event (P = .010). The plaques of alcohol consumers in the femoral group contained significantly smaller lipid cores and less macrophage infiltration than in abstainers. In the carotid group, the major cardiovascular event rate was similar in all three groups, and in addition, no difference in plaque composition was observed. CONCLUSIONS This study shows an inverse relationship between alcohol use and major cardiovascular events after endarterectomy for lower extremity arterial occlusive disease, accompanied by a more stable plaque phenotype. However, no such relationship could be observed for patients with cerebrovascular disease.
Collapse
|
61
|
Peeters W, Moll FL, Vink A, van der Spek PJ, de Kleijn DP, de Vries JPP, Verheijen JH, Newby AC, Pasterkamp G. Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome. Eur Heart J 2011; 32:2314-25. [DOI: 10.1093/eurheartj/ehq517] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
62
|
Age and coumarin-type anticoagulation are associated with the occurrence of intraplaque hemorrhage, while statins are associated less with intraplaque hemorrhage: A large histopathological study in carotid and femoral plaques. Atherosclerosis 2011; 214:139-43. [DOI: 10.1016/j.atherosclerosis.2010.10.022] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/15/2010] [Revised: 10/06/2010] [Accepted: 10/16/2010] [Indexed: 11/20/2022]
|
63
|
Peeters W, de Kleijn DPV, Vink A, van de Weg S, Schoneveld AH, Sze SK, van der Spek PJ, de Vries JPPM, Moll FL, Pasterkamp G. Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events. Eur Heart J 2010; 32:1758-68. [PMID: 21059735 DOI: 10.1093/eurheartj/ehq387] [Citation(s) in RCA: 75] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
AIMS There is an increasing need for translational studies identifying molecular targets contributing to atherosclerotic plaque destabilization. Local molecular plaque markers that are related to plaque vulnerability may hold predictive value to identify patients who are at increased risk to suffer from cardiovascular events. Animal studies revealed that adipocyte fatty acid binding protein (FABP4) is associated with the progression of atherosclerosis; however, FABP4 expression studies in human atherosclerotic plaques are lacking. We investigated FABP4 expression in carotid atherosclerotic lesions in relation to plaque composition and future cardiovascular events. METHODS AND RESULTS Atherosclerotic plaques were obtained from 561 patients undergoing carotid endarterectomy (CEA). Plaques were analysed for the presence of macrophages, lipid core, smooth-muscle cells, collagen, calcification, and intraplaque haemorrhage. Patients were followed for 3 years after CEA. The primary outcome was defined as the composite of vascular death, vascular event, and surgical or percutaneous vascular intervention. Fatty acid binding protein levels correlated with unstable plaque characteristics and symptomatic lesions. Patients with increased FABP4 plaque levels showed a two-fold increased risk [HR = 1.99, 95% confidence interval (95% CI) (1.30-3.04)] (P = 0.005) to reach the primary outcome during follow-up. Increased FABP4 levels related to primary outcome, independent from general cardiovascular risk factors [HR = 1.33, 95% CI (1.08-1.65)] (P = 0.008). CONCLUSION FABP4 levels in atherosclerotic lesions are associated with an unstable plaque phenotype and an increased risk for cardiovascular events during follow-up. Besides risk stratification for adverse future cardiovascular events, the outcome of the present study supports the relevance of exploring FABP4 antagonists as a potential pharmaceutical intervention to treat atherosclerotic disease progression.
Collapse
Affiliation(s)
- Wouter Peeters
- Experimental Cardiology Laboratory, Division Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
64
|
Derksen WJ, de Vries JPP, Vink A, Velema E, Vos JA, de Kleijn D, Moll FL, Pasterkamp G. Histologic atherosclerotic plaque characteristics are associated with restenosis rates after endarterectomy of the common and superficial femoral arteries. J Vasc Surg 2010; 52:592-9. [DOI: 10.1016/j.jvs.2010.03.063] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2010] [Revised: 03/23/2010] [Accepted: 03/24/2010] [Indexed: 11/28/2022]
|
65
|
Hellings WE, Peeters W, Moll FL, Piers SR, van Setten J, Van der Spek PJ, de Vries JPP, Seldenrijk KA, De Bruin PC, Vink A, Velema E, de Kleijn DP, Pasterkamp G. Composition of Carotid Atherosclerotic Plaque Is Associated With Cardiovascular Outcome. Circulation 2010; 121:1941-50. [DOI: 10.1161/circulationaha.109.887497] [Citation(s) in RCA: 329] [Impact Index Per Article: 23.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Willem E. Hellings
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Wouter Peeters
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Frans L. Moll
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Sebastiaan R.D. Piers
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Jessica van Setten
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Peter J. Van der Spek
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Jean-Paul P.M. de Vries
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Kees A. Seldenrijk
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Peter C. De Bruin
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Aryan Vink
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Evelyn Velema
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Dominique P.V. de Kleijn
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| | - Gerard Pasterkamp
- From the Department of Vascular Surgery (W.E.H., W.P., F.L.M., S.R.D.P.), Experimental Cardiology Laboratory (W.P., J.v.S., E.V., G.P.), and Department of Pathology (A.V.), University Medical Center Utrecht, Utrecht; Interuniversity Cardiology Institute of the Netherlands, Utrecht (W.P., D.P.V.d.K.); Department of Bioinformatics, Erasmus Medical Center Rotterdam, Rotterdam (P.J.V.d.S.); and Departments of Vascular Surgery (J.P.M.d.V.) and Pathology (K.A.S., P.C.D.B.), St Antonius Hospital Nieuwegein
| |
Collapse
|
66
|
Taleb S, Romain M, Ramkhelawon B, Uyttenhove C, Pasterkamp G, Herbin O, Esposito B, Perez N, Yasukawa H, Van Snick J, Yoshimura A, Tedgui A, Mallat Z. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. ACTA ACUST UNITED AC 2009; 206:2067-77. [PMID: 19737863 PMCID: PMC2757872 DOI: 10.1084/jem.20090545] [Citation(s) in RCA: 311] [Impact Index Per Article: 20.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Atherosclerosis is an inflammatory vascular disease responsible for the first cause of mortality worldwide. Recent studies have clearly highlighted the critical role of the immunoinflammatory balance in the modulation of disease development and progression. However, the immunoregulatory pathways that control atherosclerosis remain largely unknown. We show that loss of suppressor of cytokine signaling (SOCS) 3 in T cells increases both interleukin (IL)-17 and IL-10 production, induces an antiinflammatory macrophage phenotype, and leads to unexpected IL-17–dependent reduction in lesion development and vascular inflammation. In vivo administration of IL-17 reduces endothelial vascular cell adhesion molecule–1 expression and vascular T cell infiltration, and significantly limits atherosclerotic lesion development. In contrast, overexpression of SOCS3 in T cells reduces IL-17 and accelerates atherosclerosis. We also show that in human lesions, increased levels of signal transducer and activator of transcription (STAT) 3 phosphorylation and IL-17 are associated with a stable plaque phenotype. These results identify novel SOCS3-controlled IL-17 regulatory pathways in atherosclerosis and may have important implications for the understanding of the increased susceptibility to vascular inflammation in patients with dominant-negative STAT3 mutations and defective Th17 cell differentiation.
Collapse
Affiliation(s)
- Soraya Taleb
- Institut National de la Santé et de la Recherche Médicale, Unit 970 and Université Paris Descartes, Paris Cardiovascular Research Center, 75015 Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
67
|
Peeters W, Hellings W, de Kleijn D, de Vries J, Moll F, Vink A, Pasterkamp G. Carotid Atherosclerotic Plaques Stabilize After Stroke. Arterioscler Thromb Vasc Biol 2009; 29:128-33. [DOI: 10.1161/atvbaha.108.173658] [Citation(s) in RCA: 135] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- W. Peeters
- From the Experimental Cardiology Laboratory (W.P., W.E.H., D.P.V.d.K., G.P.), the Department of Vascular Surgery (W.E.H., F.L.M.), and the Department of Pathology (A.V.), University Medical Centre Utrecht; Interuniversity Cardiology Institute of the Netherlands (W.P., D.P.V.d.K.); and the Department of Vascular Surgery (J.P.P.M.d.V.), St. Antonius Hospital, Nieuwegein, The Netherlands
| | - W.E. Hellings
- From the Experimental Cardiology Laboratory (W.P., W.E.H., D.P.V.d.K., G.P.), the Department of Vascular Surgery (W.E.H., F.L.M.), and the Department of Pathology (A.V.), University Medical Centre Utrecht; Interuniversity Cardiology Institute of the Netherlands (W.P., D.P.V.d.K.); and the Department of Vascular Surgery (J.P.P.M.d.V.), St. Antonius Hospital, Nieuwegein, The Netherlands
| | - D.P.V. de Kleijn
- From the Experimental Cardiology Laboratory (W.P., W.E.H., D.P.V.d.K., G.P.), the Department of Vascular Surgery (W.E.H., F.L.M.), and the Department of Pathology (A.V.), University Medical Centre Utrecht; Interuniversity Cardiology Institute of the Netherlands (W.P., D.P.V.d.K.); and the Department of Vascular Surgery (J.P.P.M.d.V.), St. Antonius Hospital, Nieuwegein, The Netherlands
| | - J.P.P.M. de Vries
- From the Experimental Cardiology Laboratory (W.P., W.E.H., D.P.V.d.K., G.P.), the Department of Vascular Surgery (W.E.H., F.L.M.), and the Department of Pathology (A.V.), University Medical Centre Utrecht; Interuniversity Cardiology Institute of the Netherlands (W.P., D.P.V.d.K.); and the Department of Vascular Surgery (J.P.P.M.d.V.), St. Antonius Hospital, Nieuwegein, The Netherlands
| | - F.L. Moll
- From the Experimental Cardiology Laboratory (W.P., W.E.H., D.P.V.d.K., G.P.), the Department of Vascular Surgery (W.E.H., F.L.M.), and the Department of Pathology (A.V.), University Medical Centre Utrecht; Interuniversity Cardiology Institute of the Netherlands (W.P., D.P.V.d.K.); and the Department of Vascular Surgery (J.P.P.M.d.V.), St. Antonius Hospital, Nieuwegein, The Netherlands
| | - A. Vink
- From the Experimental Cardiology Laboratory (W.P., W.E.H., D.P.V.d.K., G.P.), the Department of Vascular Surgery (W.E.H., F.L.M.), and the Department of Pathology (A.V.), University Medical Centre Utrecht; Interuniversity Cardiology Institute of the Netherlands (W.P., D.P.V.d.K.); and the Department of Vascular Surgery (J.P.P.M.d.V.), St. Antonius Hospital, Nieuwegein, The Netherlands
| | - G. Pasterkamp
- From the Experimental Cardiology Laboratory (W.P., W.E.H., D.P.V.d.K., G.P.), the Department of Vascular Surgery (W.E.H., F.L.M.), and the Department of Pathology (A.V.), University Medical Centre Utrecht; Interuniversity Cardiology Institute of the Netherlands (W.P., D.P.V.d.K.); and the Department of Vascular Surgery (J.P.P.M.d.V.), St. Antonius Hospital, Nieuwegein, The Netherlands
| |
Collapse
|
68
|
Rodriguez-Feo JA, Hellings WE, Moll FL, De Vries JPPM, van Middelaar BJ, Algra A, Sluijter J, Velema E, van der Broek T, Sessa WC, De Kleijn DPV, Pasterkamp G. Caveolin-1 influences vascular protease activity and is a potential stabilizing factor in human atherosclerotic disease. PLoS One 2008; 3:e2612. [PMID: 18596970 PMCID: PMC2432041 DOI: 10.1371/journal.pone.0002612] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2008] [Accepted: 05/30/2008] [Indexed: 11/19/2022] Open
Abstract
Caveolin-1 (Cav-1) is a regulatory protein of the arterial wall, but its role in human atherosclerosis remains unknown. We have studied the relationships between Cav-1 abundance, atherosclerotic plaque characteristics and clinical manisfestations of atherosclerotic disease.We determined Cav-1 expression by western blotting in atherosclerotic plaques harvested from 378 subjects that underwent carotid endarterectomy. Cav-1 levels were significantly lower in carotid plaques than non-atherosclerotic vascular specimens. Low Cav-1 expression was associated with features of plaque instability such as large lipid core, thrombus formation, macrophage infiltration, high IL-6, IL-8 levels and elevated MMP-9 activity. Clinically, a down-regulation of Cav-1 was observed in plaques obtained from men, patients with a history of myocardial infarction and restenotic lesions. Cav-1 levels above the median were associated with absence of new vascular events within 30 days after surgery [0% vs. 4%] and a trend towards lower incidence of new cardiovascular events during longer follow-up. Consistent with these clinical data, Cav-1 null mice revealed elevated intimal hyperplasia response following arterial injury that was significantly attenuated after MMP inhibition. Recombinant peptides mimicking Cav-1 scaffolding domain (Cavtratin) reduced gelatinase activity in cultured porcine arteries and impaired MMP-9 activity and COX-2 in LPS-challenged macrophages. Administration of Cavtratin strongly impaired flow-induced expansive remodeling in mice.This is the first study that identifies Cav-1 as a novel potential stabilizing factor in human atherosclerosis. Our findings support the hypothesis that local down-regulation of Cav-1 in atherosclerotic lesions contributes to plaque formation and/or instability accelerating the occurrence of adverse clinical outcomes. Therefore, given the large number of patients studied, we believe that Cav-1 may be considered as a novel target in the prevention of human atherosclerotic disease and the loss of Cav-1 may be a novel biomarker of vulnerable plaque with prognostic value.
Collapse
Affiliation(s)
- Juan A. Rodriguez-Feo
- Department of Cardiology, Experimental Cardiology Laboratory, University Medical Center, Utrecht, The Netherlands
| | - Willem E. Hellings
- Department of Vascular Surgery, University Medical Center, Utrecht, The Netherlands
| | - Frans L. Moll
- Department of Vascular Surgery, University Medical Center, Utrecht, The Netherlands
| | | | - Ben J. van Middelaar
- Department of Cardiology, Experimental Cardiology Laboratory, University Medical Center, Utrecht, The Netherlands
| | - Ale Algra
- Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands
- Department of Neurology, Rudolf Magnus Institute, UMC Utrecht, Utrecht, The Netherlands
| | - Joost Sluijter
- Department of Cardiology, Experimental Cardiology Laboratory, University Medical Center, Utrecht, The Netherlands
| | - Evelyn Velema
- Department of Cardiology, Experimental Cardiology Laboratory, University Medical Center, Utrecht, The Netherlands
| | - Theo van der Broek
- Department of Cardiology, Experimental Cardiology Laboratory, University Medical Center, Utrecht, The Netherlands
| | - William C. Sessa
- Department of Pharmacology, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America
| | - Dominique P. V. De Kleijn
- Department of Cardiology, Experimental Cardiology Laboratory, University Medical Center, Utrecht, The Netherlands
- Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands
| | - Gerard Pasterkamp
- Department of Cardiology, Experimental Cardiology Laboratory, University Medical Center, Utrecht, The Netherlands
- * E-mail:
| |
Collapse
|